| Protocol ID |
|
Title |
|
| E1808 |
|
A Randomized Phase II Trial of Sunitinib/ Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features
Keywords: Renal Cell Carcinoma with Sarcomatoid Features |
|
| RTOG 0534 |
|
A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy
Keywords: Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy |
|
| In-House |
|
Management of Intra-Fractional Prostate Motion During Radiation Therapy
Keywords: radiation therapy |
|
| SWOG 0931 |
|
EVEREST EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Keywords: Renal cancer |
|
| In-House |
|
A Phase II Trial of High-Dose Pelvic Lymph Node IMRT (Intensity Modulated Radiation Therapy) and Hypofractionated Prostate IMPRT for High Risk Prostate Cancer Patients
Keywords: High Risk Prostate Cancer Patients |
|
| In-House: BCG |
|
Safety of Biclutamide in chemoprevention of transitional cell carcinoma of the bladder treated with BCG
Keywords: transitional cell carcinoma of the bladder treated with BCG |
|
| In-house |
|
Prostate Cancer, Prostate Tissue, Quantitative Measurements of Parameters Governing Thermoacoustic Contrast
Keywords: Prostate Cancer |
|
| Industry- Abiraterone Acetate |
|
A Multicenter, Open-label, Single-arm, Phase 2 Study of Abiraterone Acetate Plus Prednisone in Subjects with Advanced Prostate Cancer Without Radiographic Evidence of Metastatic Disease
Keywords: Advanced Prostate Cancer |
|
| RTOG 0815 |
|
A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
Keywords: Intermediate-Risk Prostate Cancer |
|
| GU09-145 |
|
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Keywords: Progressive Metastatic Clear Cell Renal Cell Carcinoma |
|
| In-House |
|
MicroRNA Distribution along Human Nephrons Bank
Keywords: bank |
|
| RTOG0924 |
|
Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Keywords: High Risk Prostate Cancer |
|
| UC 09-128B |
|
The Impact of a Decision Aid for Hormone Therapy for Prostate Cancer Recurrence on Patients Anxiety, Decisional Conflict, and Knowledge: A Randomized Trial
Keywords: Prostate Cancer Recurrence |
|
| In-House — MRI |
|
Investigation of the Utility of Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning
Keywords: Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning (Brain, Breast, Head & Neck, Lung, Cervix, Sarcoma, Prostate, or Liver and Liver Mets) |
|
| RTOG 0938 |
|
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Keywords: Prostate, Radiotherapy |
|
| C90601 |
|
A Randomized Double-Blind Phase III Study Comparing Gemcitabine, Cisplatin and Bevacizumab to Gemcitabine, Cisplatin and Placebo in Patients with Advanced Transitional Cell Carcinoma
Keywords: Advanced Transitional Cell Carcinoma |
|
| In-house psychosocial |
|
Study Analyzing the Use of the Dialectical Behavior Therapy (DBT) Skills Set and Psychosocial Stress with Cancer Patients
Keywords: Breast, Gyn, GI, GU Dialectical Behavior Therapy (DBT) |
|
| Industry — Prostate |
|
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 (ASP9785) vs. Bicalutamide in Castrate Men with Metastatic Prostate Cancer
Keywords: Castrate Men with Metastatic Prostate Cancer |
|
| Industry — Prostate |
|
A Randomized, Double-Blind, Phase 3 Efficacy Trial of PROSTVAC± GM-CSF in Men with Asymptomatic or Minimally Symptomatic Metastatic, Castrate-Resistant Adenocarcinoma of the Prostate
Keywords: Metastatic, Castrate-Resistant Adenocarcinoma of the Prostate |